RARE ALERT: Ongoing Investigation Into Ultragenyx Pharmaceutical Inc. – Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Ultragenyx Pharmaceutical Inc. ("Ultragenyx Pharmaceutical Inc.") (NASDAQ:RARE) concerning potential violations of the federal securities laws. What Happened? • On December 29, 2025, Ultragenyx announced the results from both its Phase III Orbit […]